Neuronix’s mission is to turn Dementia into a Manageable Chronic Disease, by introducing new methods for modifying the course of treatment for neurodegenerative diseases and in particular Alzheimer Disease (AD) thus offering hope and long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by an Advisory Board made up of key opinion leaders in the field, Neuronix’s neuroAD technology is currently undergoing advanced clinical trials in major medical centers across the globe.
Technology: Others
Industry: Preventive Medicine
Headquarters: Yoqne`am `illit, Israel
Founded Date: 2008
Employees Number: 11-50
Funding Status: N/A
Total Funding: $5.5M
Estimated Revenue: $1M to $10M

Visit Website
Register and Claim Ownership